Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial

Navin Pinto, Steven G. DuBois, Araz Marachelian, Scott J. Diede, Agne Taraseviciute, Julia L. Glade Bender, Denice Tsao-Wei, Susan G. Groshen, Joel M. Reid, Daphne A. Haas-Kogan, C. Patrick Reynolds, Min H. Kang, Meredith S. Irwin, Margaret E. Macy, Judith G. Villablanca, Katherine K. Matthay, Julie R. Park

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of vorinostat in combination with isotretinoin in patients with refractory/recurrent neuroblastoma: A new approaches to Neuroblastoma Therapy (NANT) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences